PDGFRα kinase inhibitor 1 产品活性：PDGFRα kinase inhibitor 1 是一种高选择性 II 型 PDGFRα 激酶抑制剂，抑制 PDGFRα 和 PDGFRβ 的 IC50 分别为 132 nM 和 6115 nM。 产品来源： https://www.medchemexpress.cn/PDGFR_alpha__kinase_inhibitor_1.html 研究领域：Protein Tyrosine Kinase/RTK 作用靶点：PDGFR In Vitro: PDGFRα kinase inhibitor 1 (CHMFL-PDGFR-159, Compound 15i) exhibits weak inhibition to DDR1 kinase (IC50: 2462±126 nM). 相关产品：Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Reprogramming Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | Multi-Target Compound Library | Bioactive Compound Library Max | Anti-Fibrosis Compound Library | Lenvatinib | Regorafenib | Sunitinib | Nintedanib | Imatinib | Ponatinib | Axitinib | Pazopanib | Crenolanib | SU 5402 | Avapritinib | Linifanib | CP-673451 | Ripretinib | Masitinib | Dovitinib | Cediranib | CHIR-124 | Tyrphostin A9 | Sennoside B | Narazaciclib | Amuvatinib 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。